Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.

NCT07363304 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis (CF)

Interventions

DRUG: Elexacaftor, Tezacaftor, Ivacaftor

Sponsor

Meyer Children's Hospital IRCCS